Exosomal miRNA signaling in Cocaine Addiction
可卡因成瘾中的外泌体 miRNA 信号传导
基本信息
- 批准号:9307767
- 负责人:
- 金额:$ 20.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-01 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AstrocytesAttenuatedBrainCell membraneCellsCocaineCocaine DependenceCorpus striatum structureDevelopmentDopamine D1 ReceptorDrug AddictionExcitatory Amino Acid Transporter 2Excitatory SynapseGlutamate ReceptorGlutamate TransporterGlutamatesHomeostasisHumanImmune signalingImpairmentIn SituIn Situ HybridizationIn VitroInjection of therapeutic agentLabelLipidsMalignant NeoplasmsMediatingMembraneMessenger RNAMicroRNAsModelingMotor NeuronsMusNeuraxisNeurogliaNeuronsNucleus AccumbensPathway interactionsPhysiologicalProcessProteinsPublishingRelapseReporterSelf AdministrationSignal TransductionStructureSubstance abuse problemSynapsesSynaptic plasticityTestingUp-RegulationVesicleVirus Diseasesanalogbasecell typecocaine relapsedrug relapsedrug seeking behaviorexosomeextracellularextracellular vesiclesfrontierin vivoinsightneurotransmissionnovelnovel strategiespostnatalpreventprotein expressiontooluptake
项目摘要
Abstract
This application is responsive to the PAR-15-284 (Extracellular Vesicles and Substance Abuse).
Cocaine self-administration significantly reduces glutamate transporter GLT1 protein expression and
impairs uptake of extracellular glutamate. Glutamate transporter GLT1 is the physiologically dominant
glutamate transporter in the mammalian central nervous system (CNS). GLT1 is selectively and abundantly
expressed in astrocytes after postnatal development. They are typically concentrated on the plasma
membranes of peri-synaptic astroglial processes where they tightly control extracellular glutamate levels to
limit the “spill-out”/“spill-over” of glutamate from excitatory synapses. The mechanisms for GLT1 dysregulation
in cocaine (and other addictive substance) self-administration are currently unknown. Exosomes are a class of
newly identified membrane vesicles (40-100nm) of endosomal origin that are secreted from cells; they contain
various biomolecules, including proteins, lipids, mRNAs and microRNAs (miRNAs). Exosome-mediated
intercellular signaling from neuron to glia and its physiological significance in the CNS are essentially unknown.
Based on our previously published and additional preliminary results, we hypothesize that exosome-
mediated transfer of mir-124 from neurons to astrocytes is altered, which underlie GLT1 dysregulation in the
cocaine addiction model. In this application, we will focus on the following aims: 1) Investigate exosome and
mir-124 transfer from neurons to astrocytes in the cocaine addiction model we will first examine
exosome secretion dynamics from striatum neuronal cultures. we will also breed CD63-eGFPf/f with dopamine
receptor D1 or D2 (Drd1 or Drd2) Cre mice that allow selective labeling of exosomes in D1+ or D2+ medium
spiny neurons (MSNs). We will then examine the transfer of labeled exosomes from D1+ or D2+ MSNs to
neighboring astrocytes in nucleus accumbens (NAc) during different stages of cocaine addiction in situ. We will
also examine changes of mir-124 levels in astrocytes by mir-124 in situ hybridization in NAc in the cocaine
model. 2) Determine whether mir-124-mediated up-regulation of GLT1 attenuates cocaine relapse-
associated synaptic activation we will perform stereotaxic injection to deliver mir-124 into NAc core during
cocaine self-administration and test whether exogenously delivered mir-124 is able to prevent GLT1 loss and
attenuate enhanced synaptic activation on MSNs in NAc during cocaine relapse.
In summary, this study will investigate alterations of exosome and mi-124 transfer from neurons to
astrocytes in the cocaine addiction model. This study will provide novel insights about the patho(physiological)
significance of exosome-mediated miRNA transfer in mammalian CNS, especially in understanding how
dysregulation of neuron to glial signaling contributes to drug addiction and relapse. Lastly, the test of mir-124's
effects on cocaine relapse-associated synaptic activation may provide a new approach to intervene cocaine
relapse.
抽象的
该应用程序响应 PAR-15-284(细胞外囊泡和药物滥用)。
可卡因自我给药显着降低谷氨酸转运蛋白 GLT1 蛋白表达
损害细胞外谷氨酸的吸收。谷氨酸转运蛋白 GLT1 是生理上的主导蛋白
哺乳动物中枢神经系统(CNS)中的谷氨酸转运蛋白。 GLT1 具有选择性和丰富性
出生后发育后在星形胶质细胞中表达。它们通常集中在等离子体上
突触周围星形胶质细胞过程的膜,它们严格控制细胞外谷氨酸水平
限制兴奋性突触中谷氨酸的“溢出”/“溢出”。 GLT1 失调的机制
可卡因(和其他成瘾物质)的自我给药目前尚不清楚。外泌体是一类
新鉴定的细胞分泌的内体来源的膜囊泡(40-100nm);它们包含
各种生物分子,包括蛋白质、脂质、mRNA 和 microRNA (miRNA)。外泌体介导
从神经元到神经胶质细胞的细胞间信号传导及其在中枢神经系统中的生理意义基本上是未知的。
根据我们之前发表的和额外的初步结果,我们假设外泌体-
mir-124 介导的从神经元到星形胶质细胞的转移发生改变,这是 GLT1 失调的基础
可卡因成瘾模型。在此应用中,我们将重点关注以下目标:1)研究外泌体和
我们将首先检查可卡因成瘾模型中 mir-124 从神经元转移到星形胶质细胞
来自纹状体神经元培养物的外泌体分泌动力学。我们还将用多巴胺培育 CD63-eGFPf/f
受体 D1 或 D2(Drd1 或 Drd2)Cre 小鼠,允许在 D1+ 或 D2+ 培养基中选择性标记外泌体
棘神经元(MSN)。然后,我们将检查标记的外泌体从 D1+ 或 D2+ MSN 转移到
在可卡因成瘾的不同阶段,伏核(NAc)中邻近的星形胶质细胞原位。我们将
还通过可卡因中的 NAc 中的 mir-124 原位杂交检查星形胶质细胞中 mir-124 水平的变化
模型。 2) 确定 mir-124 介导的 GLT1 上调是否会减弱可卡因复吸 -
相关的突触激活,我们将进行立体定位注射,将 mir-124 递送到 NAc 核心中
可卡因自我给药并测试外源递送的 mir-124 是否能够防止 GLT1 丢失和
减弱可卡因复吸期间 NAc 中 MSN 上增强的突触激活。
总之,本研究将研究外泌体和 mi-124 从神经元转移到
可卡因成瘾模型中的星形胶质细胞。这项研究将为病理(生理)提供新的见解
外泌体介导的 miRNA 在哺乳动物中枢神经系统中转移的重要性,特别是在了解如何
神经元与神经胶质信号传导的失调会导致药物成瘾和复发。最后是mir-124的测试
对可卡因复发相关突触激活的影响可能提供干预可卡因的新方法
复发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yongjie Yang其他文献
Yongjie Yang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yongjie Yang', 18)}}的其他基金
Dysfunctional Astroglial Exosome to (motor) Neuron Axon Signaling in ALS
ALS 中星形胶质细胞外泌体与(运动)神经元轴突信号传导功能失调
- 批准号:
10556338 - 财政年份:2022
- 资助金额:
$ 20.63万 - 项目类别:
Dysfunctional astroglial exosome to (motor) neuron axon signaling in ALS
ALS 中星形胶质细胞外泌体与(运动)神经元轴突信号传导功能失调
- 批准号:
10364034 - 财政年份:2022
- 资助金额:
$ 20.63万 - 项目类别:
Exosomal miRNA in neuron to astroglial communication in the CNS
中枢神经系统神经元与星形胶质细胞通讯中的外泌体 miRNA
- 批准号:
10653994 - 财政年份:2020
- 资助金额:
$ 20.63万 - 项目类别:
Exosomal miRNA in neuron to astroglial communication in the CNS
中枢神经系统神经元与星形胶质细胞通讯中的外泌体 miRNA
- 批准号:
10435455 - 财政年份:2020
- 资助金额:
$ 20.63万 - 项目类别:
Exosomal miRNA in neuron to astroglial communication in the CNS
中枢神经系统神经元与星形胶质细胞通讯中的外泌体 miRNA
- 批准号:
10621422 - 财政年份:2020
- 资助金额:
$ 20.63万 - 项目类别:
Exosomal miRNA in neuron to astroglial communication in the CNS
中枢神经系统神经元与星形胶质细胞通讯中的外泌体 miRNA
- 批准号:
10200175 - 财政年份:2020
- 资助金额:
$ 20.63万 - 项目类别:
Astroglia-Mediated Pathogenic Mechanisms in Fragile X Syndrome (FXS)
星形胶质细胞介导的脆性 X 综合征 (FXS) 致病机制
- 批准号:
10671282 - 财政年份:2016
- 资助金额:
$ 20.63万 - 项目类别:
Exosomes, MiRNAs and Astroglial Glutamate Transporter EAAT2/GLT1 Regulation
外泌体、miRNA 和星形胶质细胞谷氨酸转运蛋白 EAAT2/GLT1 调节
- 批准号:
8902283 - 财政年份:2014
- 资助金额:
$ 20.63万 - 项目类别:
Exosomes, MiRNAs and Astroglial Glutamate Transporter EAAT2/GLT1 Regulation
外泌体、miRNA 和星形胶质细胞谷氨酸转运蛋白 EAAT2/GLT1 调节
- 批准号:
8821167 - 财政年份:2014
- 资助金额:
$ 20.63万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 20.63万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 20.63万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 20.63万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 20.63万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 20.63万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 20.63万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 20.63万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 20.63万 - 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 20.63万 - 项目类别:
Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 20.63万 - 项目类别:
Idea to Innovation














{{item.name}}会员




